Dashboard
Manage Tickers

TNXPTonix Pharmaceuticals Holdi...

Nasdaq tonixpharma.com


$ 0.44 $ 0.00 (-0.54 %)    

Monday, 19-Aug-2024 15:59:32 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 481.15 $ 6.24 (1.31 %)
DIA $ 409.09 $ 2.37 (0.58 %)
SPY $ 559.11 $ 5.30 (0.96 %)
TLT $ 97.90 $ 0.45 (0.46 %)
GLD $ 231.62 $ -0.38 (-0.16 %)
$ 0.445
$ 0.43 x 100
-- x --
-- - --
$ 0.40 - $ 32.32
290,466,024
na
1.82M
$ -0.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-16-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 03-13-2023 12-31-2022 10-K
8 11-07-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-14-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-15-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-12-2020 03-31-2020 10-Q
19 03-24-2020 12-31-2019 10-K
20 11-08-2019 09-30-2019 10-Q
21 08-12-2019 06-30-2019 10-Q
22 05-13-2019 03-31-2019 10-Q
23 03-18-2019 12-31-2018 10-K
24 11-09-2018 09-30-2018 10-Q
25 08-13-2018 06-30-2018 10-Q
26 05-11-2018 03-31-2018 10-Q
27 03-09-2018 12-31-2017 10-K
28 11-06-2017 09-30-2017 10-Q
29 08-11-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 04-13-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-05-2016 06-30-2016 10-Q
34 05-06-2016 03-31-2016 10-Q
35 03-03-2016 12-31-2015 10-K
36 11-06-2015 09-30-2015 10-Q
37 08-07-2015 06-30-2015 10-Q
38 05-08-2015 03-31-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 11-07-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

tonix-pharmaceuticals-enrolls-first-patient-in-phase-2-catalyst-study-of-tnx-1300-for-treatment-of-cocaine-intoxication
Tonix Pharmaceuticals Enrolls First Patien...
08/20/2024 11:00:57

why-nikola-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Nikola Shares Are Trading Lower By Aro...
08/19/2024 17:37:46

tonix-pharmaceuticals-q2-2024-gaap-eps-1928-misses-327-estimate-sales-2208m-miss-3500m-estimate
Tonix Pharmaceuticals Q2 2024 GAAP EPS $(1...
08/19/2024 10:06:29

tonix-pharmaceuticals-live-virus-vaccine-candidate-shows-long-term-protection-from-mpox-smallpox-with-1-dose-animal-study-suggests
Tonix Pharmaceuticals' Live Virus Vaccine ...
08/16/2024 17:29:18

Tonix Pharmaceuticals advances TNX-801, a live attenuated horsepox virus vaccine for mpox and infectious diseases, with promisi...

tonix-pharmaceuticals-provides-update-on-development-of-its-single-dose-live-attenuated-virus-vaccine-candidate-for-mpox-company-says-tnx-801-will-provide-long-term-protection-from-mpox--smallpox-with-one-dose
Tonix Pharmaceuticals Provides Update On D...
08/16/2024 11:12:37

Core News & Articles
Vaccine Group Gavi Says It Has Up To $500M...
08/15/2024 17:02:57

- Reuters

Core News & Articles
WHO Says Actively Engaging With Swedish He...
08/15/2024 16:52:17

- Reuters

Core News & Articles
WHO Says Expert Committee Will Propose Ado...
08/14/2024 17:55:52

- Reuters

Core News & Articles
WHO Director-General Tedros Adhanom Ghebre...
08/14/2024 17:27:30

https://x.com/i/broadcasts/1kvJpbgRNWgKE

Core News & Articles
WHO Press Conference On Potential Mpox Eme...
08/14/2024 17:25:05

https://x.com/i/broadcasts/1kvJpbgRNWgKE

Core News & Articles
Africa CDC Declares Mpox A Public Health E...
08/13/2024 13:51:36

- Director General

tonix-pharmaceuticals-presented-data-and-analyses-of-tnx-102-sl-treatment-effects-on-fibromyalgia-at-the-iasp-2024-world-congress-on-pain
Tonix Pharmaceuticals Presented Data And A...
08/12/2024 12:01:31

Bedtime TNX-102 SL (sublingual cyclobenzaprine HCl) treatment in the Phase 3 RESILIENT study resulted in statistically signific...

Core News & Articles
Africa CDC Plans To Declare Regional Mpox ...
08/08/2024 15:45:04

- Bloomberg

tonix-pharmaceuticals-announces-publication-in-microorganisms-of-technology-that-expands-companys-capabilities-in-generating-potential-therapeutic-fully-human-antibodies-against-sars-cov-2-and-other-pathogens
Tonix Pharmaceuticals Announces Publicatio...
08/06/2024 12:03:51

High-throughput, high-content imaging-based assay developed to screen convalescent sera for neutralizing antibodies to SARS-CoV...

Core News & Articles
'WHO Warns On Deadlier Strain Of Mpox' - A...
08/05/2024 16:09:25

https://www.axios.com/2024/08/05/mpox-who-warning-africaThe World Health Organization is weighing discussions on whether to dec...

tonix-pharmaceuticals-fibromyalgia-treatment-receives-fda-fast-track-designation
Tonix Pharmaceuticals' Fibromyalgia Treatm...
08/01/2024 11:49:43

The FDA has granted Tonix Pharmaceuticals (NASDAQ:TNXP) a fully integrated biopharmaceutical company Fast Track designation for...

tonix-pharmaceuticals-announces-potential-impact-of-the-us-national-academies-new-definition-of-long-covid-on-the-size-of-the-fibromyalgia-market-for-tonmya
Tonix Pharmaceuticals Announces Potential ...
07/31/2024 12:16:04

Fibromyalgia is a "diagnosable condition" in people suffering from Long COVID according to NASEM1 Diagnosing fibromyalg...

tonix-pharmaceuticals-awarded-up-to-34m-ota-by-us-defense-threat-reduction-agency-to-develop-broad-spectrum-antiviral-agents-focus-on-tnx-4200-program-for-military-medical-readiness-in-biological-threat-environments-supports-preclinical-evaluation-and-phase-1-clinical-study
Tonix Pharmaceuticals Awarded Up To $34M O...
07/29/2024 13:04:06

tonix-pharmaceuticals-announces-fda-fast-track-designation-for-tonmya-to-treat-fibromyalgia-nda-submission-on-track-for-second-half-of-2024-potential-to-be-first-new-fibromyalgia-drug-in-over-15-years
Tonix Pharmaceuticals Announces FDA Fast T...
07/25/2024 12:03:16

alliance-global-partners-maintains-buy-on-tonix-pharmaceuticals-raises-price-target-to-11
Alliance Global Partners Maintains Buy on ...
07/22/2024 15:59:12

Alliance Global Partners analyst James Molloy maintains Tonix Pharmaceuticals (NASDAQ:TNXP) with a Buy and raises the price ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION